Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Walker & Dunlop (WD) Gains from Investment Securities (2017 - 2025)

Historic Gains from Investment Securities for Walker & Dunlop (WD) over the last 13 years, with Q3 2025 value amounting to $4.7 million.

  • Walker & Dunlop's Gains from Investment Securities fell 6045.44% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$57.9 million, marking a year-over-year increase of 367.68%. This contributed to the annual value of -$50.3 million for FY2024, which is 1948.64% up from last year.
  • Walker & Dunlop's Gains from Investment Securities amounted to $4.7 million in Q3 2025, which was down 6045.44% from $7.8 million recorded in Q2 2025.
  • In the past 5 years, Walker & Dunlop's Gains from Investment Securities ranged from a high of $39.4 million in Q2 2022 and a low of -$89.2 million during Q4 2023
  • Over the past 5 years, Walker & Dunlop's median Gains from Investment Securities value was $7.8 million (recorded in 2025), while the average stood at $560842.1.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first skyrocketed by 269465.07% in 2021, then plummeted by 377653.61% in 2023.
  • Walker & Dunlop's Gains from Investment Securities (Quarter) stood at $4.7 million in 2021, then tumbled by 48.39% to $2.4 million in 2022, then crashed by 3776.54% to -$89.2 million in 2023, then grew by 10.95% to -$79.4 million in 2024, then skyrocketed by 105.96% to $4.7 million in 2025.
  • Its Gains from Investment Securities was $4.7 million in Q3 2025, compared to $7.8 million in Q2 2025 and $9.0 million in Q1 2025.